Physician profile
Daniel M Weber
NPI 1972781961
$5,066.12
in general payments reported to CMS, 2019-2025
10 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $38.38 · 2021: $1,033 · 2022: $2,602 · 2023: $312 · 2024: $256 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,392.42 | 2021-2022 | |
| Biohorizons Implant Systems INC. | $440.99 | 2019-2023 | Biohorizons |
| Zimvie INC. | $381.64 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $337.80 | 2019-2025 | Biomaterials, Geistlich Bio-Gide, Bio-Materials |
| Straumann USA LLC | $188.40 | 2019-2023 | |
| Dentsply Sirona INC | $125.06 | 2019-2025 | Q-Mix |
| Nobel Biocare USA | $77.30 | 2021-2022 | |
| Keystone Dental INC. | $51.43 | 2019 | |
| Dexcel Pharma Technologies LTD. | $47.54 | 2019 | |
| Implant Direct Sybron International LLC | $23.54 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.